NHS Steroid Treatment Cards: Essential Safety for Patients

The NHS Steroid Treatment Card: A Comprehensive Guide to Corticosteroid Management

Corticosteroid medications represent one of the most widely prescribed therapeutic interventions in modern medicine, yet they carry significant risks that require careful monitoring and patient education. The National Health Service (NHS) in the United Kingdom has implemented a standardized steroid treatment card system to improve patient safety and ensure continuity of care across healthcare settings. This paper examines the purpose, implementation, and clinical significance of the NHS steroid treatment card, with particular attention to its relevance for older adults and individuals living with disabilities. Through exploration of the physiological mechanisms underlying steroid therapy risks, practical guidance for card usage, and consideration of vulnerable populations, this work provides a comprehensive resource for patients, caregivers, and healthcare professionals navigating the complexities of long-term corticosteroid treatment.

Main Content

Introduction to Corticosteroids and Their Clinical Applications

Corticosteroids, often simply called steroids in medical contexts, are synthetic versions of hormones naturally produced by the adrenal glands. These medications have revolutionized the treatment of numerous conditions since their introduction in the 1950s, earning their discoverers the Nobel Prize in Physiology or Medicine (Hench et al., 1950). Unlike anabolic steroids associated with athletic performance enhancement, corticosteroids function primarily as powerful anti-inflammatory and immunosuppressive agents.

The clinical applications of corticosteroids span virtually every medical specialty. Respiratory conditions such as asthma and chronic obstructive pulmonary disease frequently require steroid treatment to reduce airway inflammation (Global Initiative for Asthma, 2023). Rheumatologists prescribe corticosteroids for rheumatoid arthritis, lupus, and polymyalgia rheumatica to control autoimmune inflammation. Dermatologists utilize these medications for severe eczema, psoriasis, and other inflammatory skin conditions. Gastroenterologists may prescribe steroids for inflammatory bowel diseases including Crohn's disease and ulcerative colitis (Rhen & Cidlowski, 2005).

For individuals with disabilities, corticosteroids often form an essential component of disease management. People with multiple sclerosis may receive high-dose steroid pulses during acute relapses to reduce inflammation in the central nervous system. Those with spinal cord injuries might be treated with steroids to minimize secondary damage. Individuals with certain muscular dystrophies or myasthenia gravis rely on immunosuppressive doses to slow disease progression or manage symptoms (Zanotti et al., 2021).

The therapeutic benefits of corticosteroids are undeniable, but these medications come with a complex risk profile that intensifies with prolonged use and higher doses. Understanding these risks forms the foundation for appreciating why the NHS developed a specialized card system for patients receiving steroid therapy.

The Physiology of Steroid Treatment and Associated Risks

To understand why steroid treatment cards are necessary, one must first grasp how corticosteroids affect the body's natural hormone production. The human body produces cortisol, a natural corticosteroid, through the hypothalamic-pituitary-adrenal (HPA) axis. This intricate system operates on a feedback loop: the hypothalamus in the brain releases corticotropin-releasing hormone, which signals the pituitary gland to produce adrenocorticotropic hormone, which in turn stimulates the adrenal glands to produce cortisol (Nicolaides et al., 2015).

When a person takes prescribed corticosteroid medications, these synthetic hormones essentially tell the body that sufficient cortisol is already present. Consequently, the hypothalamus and pituitary gland reduce their signaling, and the adrenal glands decrease their natural cortisol production. This suppression can occur relatively quickly, sometimes within weeks of starting moderate to high-dose steroid therapy. The longer and higher the steroid dose, the more profound the suppression becomes.

The critical danger emerges when steroid treatment is stopped suddenly or when the body experiences stress. Under normal circumstances, the adrenal glands would respond to physical stress such as infection, injury, or surgery by producing additional cortisol to help the body cope. However, in someone whose HPA axis has been suppressed by steroid medication, the adrenal glands may not be able to respond adequately. This condition, known as adrenal insufficiency or adrenal crisis, can be life-threatening (Dinsen et al., 2013).

Symptoms of adrenal crisis include severe weakness, confusion, abdominal pain, low blood pressure, and loss of consciousness. Without prompt treatment with intravenous steroids, adrenal crisis can lead to shock and death. This risk persists not only during active steroid treatment but can continue for many months after stopping steroids, as the HPA axis requires time to recover its normal function.

Beyond adrenal suppression, long-term corticosteroid use carries numerous other health risks. Bone density decreases, increasing the risk of osteoporosis and fractures, particularly concerning for older adults who already face age-related bone loss (Compston, 2018). Blood sugar levels may rise, potentially causing steroid-induced diabetes. Blood pressure can increase, straining the cardiovascular system. The immune system becomes suppressed, making infections more likely and potentially more severe. Psychological effects including mood changes, anxiety, and depression may occur. Weight gain, muscle weakness, skin thinning, easy bruising, and cataracts represent additional common side effects (Liu et al., 2013).

For seniors and individuals with disabilities, these risks often carry amplified significance. An older adult with osteoporosis who experiences a steroid-related fracture may face prolonged immobility, increasing risks of pneumonia and blood clots. Someone with limited mobility due to a disability may find steroid-induced muscle weakness particularly debilitating. A person managing diabetes alongside their primary condition faces additional complexity when steroids affect blood glucose control.

The Development and Purpose of the NHS Steroid Treatment Card

Recognizing the serious risks associated with corticosteroid therapy and the critical importance of ensuring all healthcare providers are aware of a patient's steroid use, the NHS developed a standardized steroid treatment card. This initiative reflects a broader movement toward patient safety and improved healthcare communication.

Prior to the current standardized system, various versions of steroid cards existed, and practices varied across different NHS trusts and healthcare settings. This inconsistency sometimes led to confusion, with healthcare providers unsure whether a patient's card was current or which steroid preparation and dose they were receiving. In emergency situations, when time is critical, such confusion could prove dangerous.

The current NHS steroid treatment card serves multiple essential functions. First, it provides a portable, immediately accessible record of a patient's steroid medication, including the specific drug, dose, and prescribing information. Second, it contains vital safety information and warnings that the patient should be aware of. Third, it alerts healthcare professionals to the patient's steroid use, prompting appropriate clinical decisions. Fourth, it reminds patients and clinicians that steroid treatment should not be stopped abruptly without medical supervision (National Patient Safety Alert, 2020).

The card is designed to be carried by the patient at all times. In emergency situations, when a patient may be unconscious or unable to communicate, the steroid card provides critical information that could save their life. For instance, if someone on long-term steroids arrives at an emergency department following a car accident, the steroid card alerts the treating physician that the patient needs stress-dose steroids to prevent adrenal crisis, even if the patient appears stable initially.

New Steroid Emergency Card: An Enhanced Safety Initiative

In 2020, the NHS introduced an updated version called the Steroid Emergency Card as part of a national Patient Safety Alert. This new card was developed following reports of patients experiencing serious harm, including deaths, because healthcare professionals were not aware of their steroid treatment during emergency situations or planned procedures (NHS England, 2020).

The Steroid Emergency Card differs from previous versions in several important ways. It uses red coloring to make it immediately recognizable as an emergency document. The design includes clearer, more prominent warnings about the risks of adrenal crisis. Specific guidance directs healthcare professionals on when to suspect adrenal crisis and how to treat it. The card explicitly states that patients on steroids may need emergency treatment with hydrocortisone injection during acute illness, injury, or before surgery.

Who needs a Steroid Emergency Card? According to NHS guidance, the card should be issued to patients who meet certain criteria related to their steroid dose and duration. Generally, patients taking oral or injectable corticosteroids equivalent to prednisolone 5 milligrams or more daily for four weeks or longer should receive a card. Patients taking lower doses for longer periods may also qualify. Additionally, anyone who has taken significant steroid doses in the past year may still be at risk of adrenal suppression and should carry the card (Mah & Burger, 2021).

The card applies to various corticosteroid formulations including prednisolone, prednisone, hydrocortisone, dexamethasone, methylprednisolone, and others when taken orally or by injection. It generally does not apply to inhaled steroids used for asthma at standard doses, topical steroid creams used on the skin, or steroid injections into joints, as these formulations typically result in much lower systemic absorption. However, high doses of inhaled steroids or very potent topical steroids used extensively can occasionally cause HPA axis suppression, so clinical judgment remains important.

Practical Guidance for Steroid Card Usage

For patients prescribed steroids meeting the criteria, receiving and properly using the Steroid Emergency Card involves several important steps. When a doctor prescribes steroids that require a card, they or the pharmacist should provide the card and ensure it is properly completed. The card should include the patient's name, date of birth, NHS number, the specific steroid medication and dose, the date treatment started, the name of the prescribing doctor, and contact information for the prescribing department or clinic.

Patients should carry the card with them at all times, ideally in a wallet or purse alongside other important documents like identification. Some people find it helpful to take a photo of their card to store on their phone as a backup. Family members or caregivers should be informed about the card and its location. If the patient has a disability affecting memory or cognition, caregivers play an especially important role in ensuring healthcare providers are informed about steroid use.

When seeking any medical care, whether from a general practitioner, emergency department, dentist, or other healthcare provider, patients should show their Steroid Emergency Card. This applies even to seemingly routine appointments, as any illness or medical procedure could potentially trigger adrenal crisis in someone with suppressed adrenal function. Before surgery, the card alerts the surgical and anesthesia teams that the patient will need additional steroid coverage during and after the procedure to compensate for the stress of surgery (Salvatori, 2019).

The card should be updated whenever the steroid dose changes significantly. If steroid treatment is discontinued, the prescribing doctor will advise how long the patient should continue carrying the card. Because the HPA axis can take many months to recover after stopping steroids, patients often need to carry the card for six to twelve months after their final steroid dose, sometimes longer depending on the duration and intensity of their treatment.

Special Considerations for Older Adults

The intersection of aging and corticosteroid therapy creates unique challenges and considerations. Older adults represent a significant proportion of patients receiving long-term steroid treatment, reflecting the higher prevalence of inflammatory and autoimmune conditions in this age group. Conditions like polymyalgia rheumatica and giant cell arteritis, which commonly affect people over sixty, often require prolonged steroid therapy (Dejaco et al., 2015).

Seniors face heightened vulnerability to steroid side effects. Age-related decreases in bone density compound steroid-induced osteoporosis, dramatically increasing fracture risk. A hip fracture in an older adult can be devastating, leading to loss of independence, nursing home placement, and increased mortality. Consequently, older adults on steroids should be particularly vigilant about bone health, typically receiving calcium and vitamin D supplementation and often bisphosphonate medications to protect bones (Weinstein, 2011).

Cognitive changes associated with aging can complicate steroid card management. An older adult with mild cognitive impairment may forget to carry their card or may not remember to show it to healthcare providers. In these situations, family involvement becomes crucial. Adult children or other caregivers should be educated about the importance of the steroid card and should ensure their loved one's medical information is readily available during appointments or emergencies.

Polypharmacy, the concurrent use of multiple medications common among older adults, creates additional complexity. Steroids can interact with numerous other drugs. They may increase blood sugar levels in people taking diabetes medications, necessitating dose adjustments. They can interact with blood thinners, affecting clotting times. They may reduce the effectiveness of certain blood pressure medications. Healthcare providers need complete information about all medications an older adult is taking, and the steroid card serves as one piece of this larger medication safety puzzle.

Visual and physical impairments common in older age can affect steroid card usage. An older adult with arthritis may struggle to retrieve a card from a wallet. Someone with vision loss may not be able to read the small print on the card. Healthcare systems should accommodate these limitations, perhaps by using larger print versions of cards or by ensuring information is available in electronic medical records that healthcare providers can access.

Older adults living in residential care facilities face unique circumstances. Care home staff should be thoroughly trained on the significance of steroid treatment cards. The card should be clearly noted in the resident's care plan, and protocols should ensure that if a resident is transferred to the hospital, their steroid card accompanies them. Communication breakdowns during care transitions represent a known patient safety risk, and the steroid card serves as a tangible tool to maintain continuity of information.

Steroid Treatment Cards and People with Disabilities

Individuals living with disabilities interact with the healthcare system frequently and often manage complex medical regimens. For many, corticosteroids form an essential part of their treatment plan. The steroid card, therefore, represents not just a safety tool but an empowerment device that helps people with disabilities communicate critical health information, particularly when they may face barriers to conventional communication.

For people with intellectual disabilities, understanding the purpose and importance of the steroid card may require adapted educational approaches. Information should be presented using clear, simple language, visual aids, and repetition. Easy-read versions of steroid safety information can help individuals understand why they need to carry the card and show it to doctors. Caregivers, support workers, and family members require thorough education to advocate effectively for the person in their care (Krahn et al., 2015).

Individuals with communication disabilities, such as those affecting speech or hearing, may find the physical card particularly valuable. Rather than needing to verbally explain their steroid use, which might be challenging or impossible depending on the communication barrier, they can simply present the card. The card speaks for them, ensuring healthcare providers receive crucial information regardless of communication limitations.

Physical disabilities affecting motor control or mobility can complicate card-carrying logistics. Someone with limited hand function may struggle to retrieve a card from a wallet. Solutions might include keeping the card in a more accessible location, such as a pocket with a lanyard, or storing a photo on a phone with voice-activated access. Healthcare providers should proactively ask about medication history rather than assuming patients will spontaneously present their cards.

People with autism spectrum disorders may have specific considerations around medical care and emergency situations. Sensory sensitivities or anxiety about medical environments might make it difficult to communicate clearly during appointments or emergencies. The steroid card provides an objective source of information that does not rely on the individual navigating social communication challenges in potentially stressful medical settings.

Disabilities that affect immune function, such as some forms of muscular dystrophy or conditions requiring immunosuppressive medications, often necessitate steroid treatment. These individuals may already be at increased risk for infections due to their underlying condition, and steroids further suppress the immune system. The steroid card alerts providers to this compounded vulnerability, prompting appropriate infection prevention measures and rapid treatment if infection occurs (Narayanaswami et al., 2021).

Mental health disabilities intersect with steroid treatment in complex ways. Corticosteroids can cause or exacerbate psychiatric symptoms including anxiety, depression, mania, and psychosis. For someone with a pre-existing mental health condition, these effects may be particularly pronounced. The steroid card provides important context if psychiatric symptoms emerge or worsen. Healthcare providers can consider whether symptoms might be steroid-induced, which would require different management approaches than a primary psychiatric episode.

Epilepsy and other neurological conditions may require steroid treatment for various reasons, such as treating inflammation associated with seizures or managing autoimmune neurological conditions. Steroids can sometimes affect seizure control, and the interaction between anti-epileptic medications and steroids requires monitoring. The steroid card ensures neurologists, emergency physicians, and other providers have critical information when treating someone with complex neurological needs.

Emergency Situations and the Steroid Card

The most critical function of the steroid card is preventing harm during medical emergencies. Understanding how the card should be used in these situations, and what healthcare providers should do when they encounter a patient with a steroid card, can literally be lifesaving.

When someone on long-term steroids becomes acutely ill with an infection such as pneumonia, severe gastroenteritis, or sepsis, their body experiences significant physiological stress. Under normal circumstances, the adrenal glands would increase cortisol production to help the body cope with this stress. However, in someone with steroid-suppressed adrenal function, this stress response cannot occur adequately. Without recognition and treatment, the patient can develop adrenal crisis characterized by profound weakness, low blood pressure, and shock (Bornstein et al., 2016).

The steroid card alerts emergency department physicians and hospital doctors to this risk. Upon identifying a patient with a steroid card who appears acutely unwell, healthcare providers should consider the possibility of adrenal insufficiency and may need to administer supplemental steroid doses beyond the patient's usual maintenance therapy. This "stress dosing" of steroids supports the body through the acute illness until recovery occurs.

Trauma situations present similar challenges. Someone on long-term steroids who sustains injuries in a fall, car accident, or other trauma needs stress-dose steroid coverage. Even if their injuries appear minor initially, the physiological stress of trauma can precipitate adrenal crisis in someone with suppressed adrenal function. Paramedics and emergency physicians rely on the steroid card to identify these high-risk patients.

Surgical procedures, whether planned or emergency, require special steroid management. Surgery represents a major physiological stressor, and patients with adrenal suppression need additional steroid coverage before, during, and after operations. For planned surgery, the patient's usual doctor typically communicates with the surgical team to arrange appropriate steroid supplementation. However, in emergency surgery situations, or when communication breaks down, the steroid card provides essential backup information (Liu et al., 2013).

Dental procedures occasionally require consideration of steroid status. While routine cleanings and simple fillings generally do not require steroid supplementation, more extensive procedures like extractions or oral surgery might. Dentists should be aware of their patients' steroid use, and patients should show their steroid card at dental appointments.

For older adults and people with disabilities who may already face healthcare disparities and communication challenges, the steroid card serves as an equalizer. It ensures their steroid treatment is not overlooked, even when they cannot advocate for themselves. This is particularly important given research showing that people with disabilities and seniors sometimes receive less thorough medical evaluations in emergency situations due to conscious or unconscious biases (Iezzoni et al., 2021).

Stopping Steroid Treatment: The Importance of Gradual Withdrawal

One of the most important warnings on the steroid treatment card concerns stopping steroids. The card explicitly states that steroid treatment should not be stopped suddenly, and this warning deserves thorough explanation.

When someone has been taking significant doses of corticosteroids for more than a few weeks, their HPA axis has become suppressed, as discussed earlier. If steroids are stopped abruptly, the body suddenly lacks both the external steroid medication and adequate internal cortisol production. This precipitates acute adrenal insufficiency, which can rapidly become life-threatening.

Instead, steroids must be tapered gradually. The tapering schedule depends on the dose, duration of treatment, and individual patient factors. Someone who took high-dose steroids for several years may require many months of gradual dose reduction to safely discontinue treatment. During the taper, the gradual reduction in steroid dose allows the HPA axis to slowly recover function. The hypothalamus and pituitary gland begin signaling again, and the adrenal glands gradually resume cortisol production (Broersen et al., 2015).

Patients should never attempt to stop steroids on their own or reduce doses faster than their doctor recommends, even if they feel well or are experiencing side effects they want to resolve. Any concerns about steroid treatment should be discussed with the prescribing doctor, who can assess whether the benefits continue to outweigh risks and can supervise safe dose reduction if appropriate.

For people with cognitive disabilities or memory problems, whether due to aging, intellectual disability, or other conditions, adhering to complex tapering schedules can be challenging. Written instructions, pill organizers, caregiver involvement, and pharmacist support can help ensure patients take the right dose at the right time. Some healthcare systems use text message reminders or phone calls to support medication adherence during critical periods like steroid tapering.

The steroid card should be retained throughout the tapering period and for a substantial time after the final dose. Even after stopping steroids completely, the HPA axis may take six to twelve months or longer to fully recover. During this recovery period, the patient remains at risk for adrenal insufficiency if they become seriously ill or require surgery. The steroid card ensures healthcare providers are aware of this recent steroid history and can provide appropriate treatment.

Monitoring and Follow-Up for Patients on Long-Term Steroids

Beyond the steroid card itself, patients on long-term corticosteroid therapy require regular monitoring and follow-up care to minimize risks and detect complications early. This comprehensive approach to steroid management is particularly important for vulnerable populations including seniors and people with disabilities.

Bone density scanning (DEXA scanning) should be performed regularly in patients on long-term steroids to assess for osteoporosis. If bone density decreases significantly, medications can be prescribed to slow or prevent further bone loss. Calcium and vitamin D supplementation typically begins when long-term steroid treatment starts, as these nutrients support bone health (Compston, 2018).

Blood pressure monitoring is essential because steroids can cause hypertension. Regular checks allow for early detection and treatment of elevated blood pressure, reducing cardiovascular risks. For older adults who may already have age-related hypertension, careful monitoring becomes even more critical.

Blood sugar testing helps identify steroid-induced diabetes. Patients should have their glucose levels checked periodically, and those with pre-existing diabetes require more frequent monitoring and often need adjustments to their diabetes medications. For someone with a disability already managing complex medications, adding diabetes management creates additional burden, making prevention and early detection particularly valuable.

Eye examinations to check for cataracts and glaucoma should occur regularly in patients on long-term steroids. Both conditions are more common with prolonged steroid use and can significantly impact quality of life, especially for people who rely heavily on vision to compensate for other disabilities or for older adults whose independence depends on driving.

Weight and body composition monitoring helps identify steroid-induced weight gain and redistribution of body fat. While often considered a cosmetic concern, these changes can have functional implications, particularly for people with mobility limitations. Additional weight can make transfers more difficult for someone using a wheelchair, and fat redistribution can affect balance in someone with gait problems.

Mental health screening should be part of routine follow-up because steroids can profoundly affect mood and cognition. Patients and caregivers should be educated about psychiatric symptoms that might emerge and encouraged to report these promptly. For individuals with pre-existing mental health conditions, close collaboration between their mental health providers and the prescribing physician is essential (Fardet et al., 2012).

Infection vigilance is crucial. Patients on steroids should be educated about their increased infection risk and should seek medical care promptly for symptoms like fever, persistent cough, or unusual pain. They should be up to date on vaccinations when possible, though live vaccines are generally contraindicated in people on immunosuppressive steroid doses. Influenza and pneumonia vaccines are particularly important for preventing serious respiratory infections.

Alternative Approaches and Steroid-Sparing Strategies

While steroids are highly effective for many conditions, their side effect profile has motivated ongoing efforts to develop alternative treatments and steroid-sparing strategies. Understanding these approaches provides context for why some patients can eventually discontinue steroids and surrender their steroid cards, while others require lifelong treatment.

For inflammatory conditions like rheumatoid arthritis and inflammatory bowel disease, newer biologic medications target specific components of the immune system rather than broadly suppressing it as steroids do. These biologics often allow patients to reduce or eliminate their steroid use while maintaining disease control. Medications like tumor necrosis factor inhibitors, interleukin inhibitors, and Janus kinase inhibitors have revolutionized treatment for many autoimmune conditions (Rubbert-Roth et al., 2018).

In respiratory diseases like asthma, inhaled steroids deliver medication directly to the airways while minimizing systemic absorption and side effects. Most people with asthma can be managed with inhaled steroids alone and do not require a steroid treatment card. Only those needing frequent courses of oral steroids or long-term oral steroid treatment for severe asthma typically need the card.

Immunosuppressive medications like methotrexate, azathioprine, and mycophenolate can sometimes reduce steroid requirements in autoimmune conditions. These medications take time to become effective but can eventually allow steroid dose reduction. While they have their own side effects and risks, the side effect profile may be more acceptable than high-dose long-term steroids for some patients.

For people with certain disabilities, particularly neuromuscular conditions, research continues into treatments that might reduce reliance on steroids. For example, in Duchenne muscular dystrophy, new genetic therapies and medications targeting inflammation through non-steroid mechanisms offer hope for reducing steroid dependence while maintaining benefits (McDonald et al., 2018).

Despite these advances, many patients continue to require steroids because no equally effective alternative exists for their condition, or because they have tried alternatives without success. For these individuals, the steroid card remains a permanent feature of their medical management.

Patient and Caregiver Education: A Critical Component

The steroid treatment card is only as effective as the knowledge and engagement of the people using it. Comprehensive patient and caregiver education forms an essential component of safe steroid management.

When steroids are first prescribed, the initiating physician should provide thorough counseling about the medication. This should include explanation of why steroids are needed, what benefits are expected, what side effects might occur, how long treatment is anticipated to last, and crucially, the importance of not stopping the medication suddenly. The steroid card should be explained in detail, with emphasis on carrying it at all times and showing it to all healthcare providers.

Written information reinforces verbal counseling and provides a reference patients can review at home. The NHS provides patient information leaflets about steroid treatment cards, available in various formats including easy-read versions for people with learning disabilities. These materials should be offered proactively to all patients starting relevant steroid treatment (NHS, 2020).

For caregivers of older adults or people with disabilities, education must extend beyond the patient themselves. Family members, home care workers, and residential care staff should understand the implications of steroid treatment. They should know where the steroid card is kept, recognize symptoms that might indicate complications like adrenal crisis or infection, and understand when to seek medical care urgently.

Patient support groups and disability organizations can provide peer education and support around steroid management. Connecting with others who have navigated similar treatments can provide practical tips and emotional support. For conditions like rheumatoid arthritis, inflammatory bowel disease, or multiple sclerosis, patient organizations often have extensive resources about managing steroid treatment.

Pharmacists represent an underutilized educational resource. Community pharmacists see patients regularly when they collect prescriptions and can reinforce key safety messages about steroid use, check that patients have their steroid cards, and answer questions. For people with mobility limitations who may receive home medication delivery, pharmacists can still provide telephone counseling and support.

Regular review of steroid knowledge should occur at follow-up appointments. Healthcare providers should not assume that information given at treatment initiation has been retained, particularly in older adults with memory changes or people with cognitive disabilities. Brief reviews of key safety points at each appointment help maintain awareness.

Healthcare System Responsibilities and Implementation

While patient engagement is crucial, healthcare systems and professionals bear significant responsibility for the successful implementation of the steroid card system. This involves multiple layers of healthcare infrastructure working together.

Prescribers must identify patients who meet criteria for a steroid card and ensure cards are issued and completed accurately. This requires clinical knowledge, awareness of current guidance, and systematic processes. Electronic prescribing systems can assist by flagging when a prescription meets steroid card criteria, prompting the prescriber to arrange for card issuance.

Pharmacists serve as a safety backstop, verifying that patients receiving qualifying steroid prescriptions have cards. Community pharmacies can stock cards and issue them when dispensing relevant prescriptions, ensuring no patient falls through gaps in the system. Hospital pharmacies should verify that inpatients on steroids have cards before discharge.

General practitioners and primary care teams should maintain awareness of which patients in their practices are on long-term steroids and should periodically verify that cards remain current. When reviewing repeat prescriptions, brief checks that patients still have their cards and understand their importance can prevent problems.

Emergency department staff should be trained to recognize steroid cards and understand their implications. Triage nurses should specifically ask about steroid use and look for steroid cards. Emergency physicians should have readily available guidance on managing adrenal insufficiency and determining appropriate stress doses of steroids.

Surgical and anesthesia teams should have protocols for identifying patients on steroids during pre-operative assessment and arranging appropriate perioperative steroid management. This requires communication between surgical teams, anesthesiologists, endocrinologists when needed, and the patient's usual prescriber.

Dental practices should incorporate questions about steroid use into their medical history forms and train staff to ask patients about steroid cards during appointments.

Care homes and residential facilities should have policies ensuring staff know which residents are on steroids and ensuring steroid cards are always accessible and accompany residents during transfers to hospital or medical appointments.

Electronic health records can facilitate steroid safety by prominently displaying steroid medication histories, automatically flagging patients who should have cards, and including clinical decision support that prompts appropriate steroid management during illness or procedures. However, electronic systems should complement, not replace, the physical card, as technology failures or lack of record access in emergencies could prove dangerous (Wang et al., 2020).

National-level guidance and monitoring help ensure consistent implementation across the healthcare system. The Medicines and Healthcare products Regulatory Agency (MHRA) and NHS England provide ongoing guidance about steroid cards and monitor safety incidents related to steroid treatment. These organizations investigate serious incidents, identify systemic problems, and issue alerts or updated guidance as needed.

International Perspectives on Steroid Safety

While this paper focuses on the NHS steroid card system in the United Kingdom, corticosteroid safety represents a global concern, and various healthcare systems have implemented different approaches to address it.

In the United States, steroid alert cards exist but are not universally standardized. Different hospitals, health systems, and pharmaceutical companies may issue varying versions of steroid warning cards. The American College of Rheumatology and Endocrine Society have published guidelines emphasizing the importance of patient education about adrenal insufficiency risks, but a uniform national card system does not exist (Dinsen et al., 2013).

Australia has implemented a National Inpatient Medication Chart that includes specific sections for documenting steroid use and has issued guidance about perioperative steroid management. Australian endocrinology organizations have developed resources about adrenal insufficiency and stress dosing similar in spirit to the NHS approach.

European countries have varying practices, with some implementing national steroid card systems and others relying more on individual physician practice and patient education. The European Medicines Agency has issued warnings about adrenal insufficiency risks with systemic and potent inhaled corticosteroids, prompting increased awareness across Europe.

Developing countries face unique challenges in steroid safety. Limited healthcare resources, less systematic medication tracking, lower health literacy, and limited access to specialist care can make steroid management more hazardous. International health organizations work to develop scalable solutions appropriate for resource-limited settings.

Comparison of these international approaches reveals that while specific implementation details vary, the core principle remains consistent: patients on long-term systemic steroids need a reliable way to communicate this information to healthcare providers, especially during emergencies. The NHS steroid card system represents one of the more comprehensive and systematized approaches globally.

Case Studies: Real-World Applications of Steroid Cards

Examining hypothetical but realistic scenarios illustrates how steroid cards function in practice and why they are so important. These case studies particularly highlight relevance to seniors and people with disabilities.

Consider Margaret, a seventy-eight-year-old woman with polymyalgia rheumatica who has been taking prednisolone 10 milligrams daily for two years. She carries her Steroid Emergency Card in her purse. One day, she develops severe pneumonia and is brought to the emergency department by ambulance, feeling very unwell and confused. She is unable to clearly communicate her medical history due to her acute illness. The paramedics find her steroid card in her purse and give it to the emergency department staff. The emergency physician recognizes that Margaret is at risk for adrenal crisis given her acute infection and long-term steroid use. Along with antibiotics for pneumonia, Margaret receives stress-dose intravenous hydrocortisone. She recovers well, and her doctors later tell her family that the steroid card likely prevented a potentially fatal complication.

Consider James, a thirty-two-year-old man with spinal muscular atrophy who uses a power wheelchair and requires assistance with most daily activities. James has been on prednisone for the past six months as part of a treatment trial for his condition. His card is kept in the backpack attached to his wheelchair, where his care workers can easily find it. James develops severe gastroenteritis with vomiting and diarrhea. His care worker, who has been educated about the steroid card's importance, brings it along when taking James to urgent care. The physician sees the card and realizes James cannot keep down his oral prednisone due to vomiting. She arranges for James to receive intravenous hydrocortisone at the hospital until his gastroenteritis resolves and he can resume oral medications.

Consider Doris, an eighty-six-year-old with moderate dementia living in a care home. She has been on prednisolone for several years for chronic obstructive pulmonary disease. Her steroid card is noted prominently in her care plan. When Doris falls and fractures her hip, requiring emergency surgery, care home staff ensure her steroid card goes with her to the hospital. The orthopedic and anesthesia teams see the card and coordinate with an endocrinologist to provide appropriate perioperative steroid coverage. Doris's surgery and recovery proceed without adrenal complications.

Consider Amir, a sixteen-year-old with cerebral palsy and a moderate intellectual disability who has been treated with dexamethasone for refractory epilepsy. His mother keeps his steroid card in a special medical information folder along with information about his seizure disorder and other health needs. When Amir requires dental work under general anesthesia, his mother provides the complete folder to the dental surgical team. Seeing the steroid card, the anesthesiologist arranges for stress-dose steroid coverage during the procedure. The surgery proceeds smoothly without complications.

These scenarios, while hypothetical, reflect real situations that occur regularly in healthcare settings. In each case, the steroid card provided critical information that directly influenced clinical management and prevented potential harm.

Future Directions and Ongoing Challenges

Despite the significant progress represented by the NHS Steroid Emergency Card, ongoing challenges and opportunities for improvement remain.

Digital health technologies offer potential enhancements to steroid safety. Electronic steroid cards accessible via smartphone apps could ensure patients always have their information available even if they lose physical cards. Integration with national health record systems could make steroid information automatically available to all healthcare providers. However, digital solutions must accommodate people without smartphones or digital literacy, including many older adults and people with certain disabilities.

Wearable medical alert devices, similar to those used for severe allergies, could supplement or replace cards for some patients. Medical alert bracelets or necklaces indicating steroid use would be visible to first responders and emergency personnel even if a patient is unconscious and unable to produce a card. This could be particularly valuable for people with epilepsy, cognitive disabilities, or other conditions where loss of consciousness occurs.

Patient education remains an ongoing challenge. Studies suggest that many patients on long-term steroids have poor understanding of adrenal insufficiency risks and may not carry their cards consistently (Mah & Burger, 2021). Innovative educational approaches using video, interactive online modules, and peer support might improve engagement and retention of critical safety information.

Healthcare provider education also requires attention. Audit studies have found that emergency department staff and surgical teams sometimes fail to recognize the significance of steroid cards or do not follow appropriate protocols when treating steroid-dependent patients. Ongoing professional education, simulation training with steroid-related scenarios, and systematic audits of steroid safety practices could improve outcomes.

Special attention to health equity is needed. People from disadvantaged socioeconomic backgrounds, ethnic minorities, people with limited English proficiency, and people with disabilities face systemic barriers in healthcare access and quality. Ensuring the steroid card system works effectively for these populations requires culturally appropriate education materials, translated cards, accessible formats, and healthcare system policies that actively address disparities.

Research into better treatments that might reduce steroid dependence continues. For many conditions currently requiring long-term steroids, ongoing scientific work seeks alternatives with fewer side effects. Success in these research endeavors could eventually reduce the number of people requiring steroid cards. However, given steroids' remarkable therapeutic efficacy, they are likely to remain important medications for decades to come.

Global health perspectives suggest that lessons from the NHS steroid card system could benefit other countries. International collaboration to share best practices in steroid safety could lead to improved outcomes worldwide. The World Health Organization and international professional societies have roles to play in disseminating effective approaches to steroid management across diverse healthcare contexts.

Where to Obtain Steroid Treatment Cards

Understanding the importance of the steroid treatment card is only useful if patients know how to actually obtain one. The process for receiving a Steroid Emergency Card involves several potential sources, each playing a role in ensuring no patient falls through the gaps.

Primary Sources for Steroid Cards

The most common source for obtaining a steroid card is the prescribing physician or specialist who initiates the corticosteroid treatment. When a doctor prescribes steroids at a dose and duration that meets the criteria for requiring a card, they should provide one during that same appointment or shortly thereafter. This might occur in various settings: a rheumatologist's office when starting treatment for lupus, a respiratory clinic when prescribing long-term steroids for severe asthma, or a hospital ward before discharging a patient on steroid therapy.

Hospital pharmacies represent another key distribution point. When patients receive their first steroid prescription as inpatients, the hospital pharmacy typically supplies the card along with the medication. Before discharge, ward staff should verify that patients have received and understand their steroid cards. For patients with cognitive disabilities or confusion, hospital staff should ensure caregivers or family members are aware of the card and its significance.

Community pharmacies serve as an important safety net in the steroid card distribution system. When dispensing steroid prescriptions that meet the criteria for requiring a card, pharmacists should check whether the patient already has one. If not, many community pharmacies stock Steroid Emergency Cards and can issue them on the spot. This is particularly valuable when patients have been prescribed steroids by locum doctors or in urgent care settings where card provision might be overlooked (NHS England, 2020).

Obtaining Cards Through Primary Care

General practice surgeries maintain supplies of Steroid Emergency Cards and can provide them to patients during routine appointments. If someone has been on steroids for some time but never received a card, they should request one from their GP or practice nurse during their next visit. Many surgeries now conduct medication reviews specifically looking for patients on long-term steroids who should have cards but don't.

For patients with mobility limitations or disabilities that make traveling to the surgery difficult, GP practices can often arrange for the card to be posted or delivered along with prescription medications. Home-visiting services can also deliver cards to housebound patients. Older adults in residential care should have their care home staff request cards on their behalf if needed.

Requesting Cards Directly

Patients who realize they should have a Steroid Emergency Card but have never received one should be proactive in requesting one. They can contact their prescribing doctor's office, their GP surgery, or their regular pharmacy. No one should feel hesitant about asking for a card - healthcare professionals recognize these are important safety tools and should respond promptly to requests. For people with communication disabilities, making such requests might require support. Caregivers, family members, or advocacy workers can contact healthcare providers on the patient's behalf. Written requests via email or patient portal systems may be easier for some individuals than telephone calls. What to Do If Cards Are Lost or Damaged Steroid Emergency Cards should be durable enough for daily carrying, but they can be lost, damaged, or accidentally destroyed. If this happens, obtaining a replacement is straightforward. Patients should contact their GP surgery, their specialist who prescribes the steroids, or their regular pharmacy. Replacement cards should be issued promptly without bureaucratic barriers.

Some patients find it helpful to keep a photograph of their completed steroid card on their smartphone as a backup. While a photo shouldn't replace the physical card, it provides emergency information if the card is temporarily unavailable. Additionally, some people request two cards - keeping one in their wallet and another in a medication storage location at home or in a hospital bag.

For individuals with memory problems or cognitive disabilities, caregivers should periodically check that the steroid card hasn't been misplaced. Establishing a consistent location for the card, such as a specific pocket in a wheelchair bag or a designated slot in a wallet, helps prevent loss.

Online and Digital Access

The NHS provides downloadable versions of the Steroid Emergency Card on its website, though these are primarily for healthcare professionals to print and issue to patients. The official cards should be completed by a healthcare professional to ensure accuracy of the information recorded.

Some NHS Trusts are piloting digital versions of steroid cards accessible through patient apps or electronic health record portals. These initiatives aim to ensure steroid information is always available even if physical cards are forgotten. However, digital solutions are still supplementary rather than replacements for physical cards, particularly given that not all patients have smartphones or digital access.

Ensuring Cards Are Properly Completed

Simply having a blank card is insufficient - the card must be properly filled out with accurate patient information. When receiving a card, patients should verify that it includes their full name, date of birth, NHS number, the specific steroid medication and dose, when treatment started, and contact information for the prescribing doctor or department.

If any information is unclear, incomplete, or becomes outdated due to dose changes, patients should have the card updated. Healthcare providers can make corrections or issue new cards as needed. For people with visual impairments, having someone verify the card information is correct and legible provides additional safety assurance.

Special Considerations for Care Settings

Patients moving between care settings - such as from hospital to home, from home to residential care, or between different care facilities - face particular risks of card-related oversights. Discharge planning should explicitly include verification that patients have appropriate steroid cards. Transfer documentation should note that the patient has a steroid card and should reference the steroid medication regimen. For children transitioning to adult care, ensuring continuity of steroid card provision is essential. Young adults with disabilities who have been on long-term steroids since childhood should maintain their cards as they age into adult healthcare services.

Advocacy and Support Organizations

Patient advocacy groups for specific conditions often provide information about steroid treatment cards and can help individuals navigate the system to obtain them. Organizations supporting people with rheumatoid arthritis, inflammatory bowel disease, asthma, or neuromuscular conditions may have resources about steroid safety and can offer guidance on ensuring proper card provision. Disability rights organizations and advocacy services can assist people with disabilities in accessing steroid cards and ensuring healthcare providers meet their responsibilities around patient safety. These organizations understand the additional barriers people with disabilities may face and can provide practical support in navigating healthcare bureaucracy.

The Role of Patient Responsibility

While healthcare systems should proactively provide steroid cards to all qualifying patients, individuals and their caregivers also bear responsibility for ensuring they have and carry their cards. Patients should not assume that because they haven't been given a card, they don't need one. Anyone on daily oral or injectable corticosteroids equivalent to prednisolone 5 milligrams or more for four weeks or longer should have a card, as should anyone who has taken such treatment within the past year.

Self-advocacy is particularly important for people who see multiple healthcare providers or who receive care in fragmented systems where communication gaps might occur. Asking directly "Should I have a steroid treatment card?" empowers patients to take an active role in their safety.

Conclusion

The NHS Steroid Emergency Card represents a simple yet potentially lifesaving intervention in the complex landscape of corticosteroid therapy. By providing a standardized method for patients to communicate their steroid use to healthcare providers, particularly during emergencies, the card addresses a critical patient safety gap. For the hundreds of thousands of people in the United Kingdom taking long-term systemic steroids, this small piece of card stock carries enormous significance.

The importance of the steroid card is magnified for vulnerable populations including older adults and people with disabilities. These individuals often face heightened risks from steroid side effects, may have communication barriers that make conveying medical information challenging, and frequently interact with multiple healthcare providers across different settings. The steroid card serves as a consistent communication tool that transcends these challenges.

Effective implementation of the steroid card system requires collaboration among all participants in healthcare: prescribers must identify appropriate patients and issue cards, pharmacists must verify and reinforce card use, patients and caregivers must understand and embrace card-carrying, and all healthcare providers from emergency physicians to dentists must recognize cards and respond appropriately. Healthcare systems must maintain infrastructure supporting these individual actions through training, clinical decision support, and quality monitoring.

While the steroid card is a crucial safety intervention, it exists within a broader context of corticosteroid management that includes careful prescribing, regular monitoring, patient education about side effects, bone and metabolic health protection, and ongoing assessment of whether steroid therapy remains appropriate. The card addresses the acute risks of adrenal insufficiency, but comprehensive steroid safety encompasses much more.

Looking forward, technological advances may offer opportunities to enhance steroid safety beyond physical cards. However, any innovations must preserve the accessibility and universality that make the current card system valuable, ensuring that all patients benefit regardless of their technological sophistication, cognitive abilities, or socioeconomic circumstances.

For patients prescribed corticosteroids meeting the criteria for a Steroid Emergency Card, understanding and utilizing this tool represents a vital aspect of self-advocacy and self-care. For healthcare professionals, recognizing and appropriately responding to steroid cards represents a fundamental patient safety responsibility. Together, these efforts help ensure that the remarkable therapeutic benefits of corticosteroid medications can be realized while minimizing preventable harm.

References

Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., & Torpy, D. J. (2016). Diagnosis and treatment of primary adrenal insufficiency: An Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 101(2), 364-389.

Broersen, L. H., Pereira, A. M., Jørgensen, J. O., & Dekkers, O. M. (2015). Adrenal insufficiency in corticosteroids use: Systematic review and meta-analysis. Journal of Clinical Endocrinology & Metabolism, 100(6), 2171-2180.

Compston, J. (2018). Glucocorticoid-induced osteoporosis: An update. Endocrine, 61(1), 7-16.

Dejaco, C., Singh, Y. P., Perel, P., Hutchings, A., Camellino, D., Mackie, S., Matteson, E. L., Dasgupta, B., & European League Against Rheumatism; American College of Rheumatology. (2015). Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: A systematic literature review informing the 2015 European League Against Rheumatism/American College of Rheumatology recommendations. Annals of the Rheumatic Diseases, 74(10), 1808-1817.

Dinsen, S., Baslund, B., Klose, M., Rasmussen, A. K., Friis-Hansen, L., Hilsted, L., & Feldt-Rasmussen, U. (2013). Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself. European Journal of Internal Medicine, 24(8), 714-720.

Fardet, L., Petersen, I., & Nazareth, I. (2012). Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. American Journal of Psychiatry, 169(5), 491-497.

Global Initiative for Asthma. (2023). Global strategy for asthma management and prevention. Global Initiative for Asthma.

Hench, P. S., Kendall, E. C., Slocumb, C. H., & Polley, H. F. (1950). Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions. Archives of Internal Medicine, 85(4), 545-666.

Iezzoni, L. I., Rao, S. R., Ressalam, J., Bolcic-Jankovic, D., Agaronnik, N. D., Donelan, K., Lagu, T., & Campbell, E. G. (2021). Physicians' perceptions of people with disability and their health care. Health Affairs, 40(2), 297-306.

Krahn, G. L., Walker, D. K., & Correa-De-Araujo, R. (2015). Persons with disabilities as an unrecognized health disparity population. American Journal of Public Health, 105(S2), S198-S206.

Liu, D., Ahmet, A., Ward, L., Krishnamoorthy, P., Mandelcorn, E. D., Leigh, R., Brown, J. P., Cohen, A., & Kim, H. (2013). A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy, Asthma & Clinical Immunology, 9(1), 30.

Mah, P. M., & Burger, D. (2021). Ensuring safe use of steroids: Adrenal insufficiency awareness initiatives. Clinical Medicine, 21(2), e231-e235.

McDonald, C. M., Henricson, E. K., Abresch, R. T., Duong, T., Joyce, N. C., Hu, F., Clemens, P. R., Hoffman, E. P., Cnaan, A., & Gordish-Dressman, H. (2018). Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: A prospective cohort study. Lancet, 391(10119), 451-461.

Narayanaswami, P., Sanders, D. B., Wolfe, G., Benatar, M., Cea, G., Evoli, A., Gilhus, N. E., Illa, I., Kuntz, N. L., Massey, J., Melms, A., Murai, H., Nicolle, M., Palace, J., Richman, D., Verschuuren, J., & Narayanaswami, P. (2021). International consensus guidance for management of myasthenia gravis: 2020 update. Neurology, 96(3), 114-122.

NHS England. (2020). Resources to support the safety of patients with adrenal insufficiency. National Patient Safety Alert.

Nicolaides, N. C., Kyratzi, E., Lamprokostopoulou, A., Chrousos, G. P., & Charmandari, E. (2015). Stress, the stress system and the role of glucocorticoids. Neuroimmunomodulation, 22(1-2), 6-19.

Rhen, T., & Cidlowski, J. A. (2005). Antiinflammatory action of glucocorticoids - New mechanisms for old drugs. New England Journal of Medicine, 353(16), 1711-1723.

Rubbert-Roth, A., Szabó, M. Z., Kedves, M., Nagy, G., Atzeni, F., & Sarzi-Puttini, P. (2018). Failure of anti-TNF treatment in patients with rheumatoid arthritis: The pros and cons of switching to another anti-TNF or to another mode of action. Autoimmunity Reviews, 17(10), 1011-1018.

Salvatori, R. (2019). Adrenal insufficiency. JAMA, 294(19), 2481-2488.

Wang, C. J., Goel, A., Trudeau, J. J., Boscardin, W. J., & Steinman, M. A. (2020). Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA Internal Medicine, 180(10), 1303-1310.

Weinstein, R. S. (2011). Clinical practice: Glucocorticoid-induced bone disease. New England Journal of Medicine, 365(1), 62-70.

Zanotti, S., Gibertini, S., & Mora, M. (2021). Altered production of extra-cellular matrix components by muscle-derived Duchenne muscular dystrophy fibroblasts before and after TGF-β1 treatment. Cell and Tissue Research, 339(2), 397-410.

Insights, Analysis, and Developments

Author Credentials: Ian is the founder and Editor-in-Chief of Disabled World, a leading resource for news and information on disability issues. With a global perspective shaped by years of travel and lived experience, Ian is a committed proponent of the Social Model of Disability-a transformative framework developed by disabled activists in the 1970s that emphasizes dismantling societal barriers rather than focusing solely on individual impairments. His work reflects a deep commitment to disability rights, accessibility, and social inclusion. To learn more about Ian's background, expertise, and accomplishments, visit his full biography.